Quantcast
Last updated on April 20, 2014 at 13:20 EDT

Latest genomics Stories

2014-01-14 23:04:55

Houston area pharmacogenomics lab utilizes regional health information network to ensure broad provider access to genetic profiles. Houston, Texas (PRWEB) January 14, 2014 Healthconnect announced today that it has become one of the first health information networks in the country to sign-on a pharmacogenomics lab, Companion Dx, for the broad dissemination of genetic test results. By making archived records available through Healthconnect, Companion Dx can ensure that genetic information...

2014-01-13 23:21:16

This report from BCC Research is an exhaustive study on the cancer profiling and pathways, giving crucial statistics and analysis on the market structure, market size, key technologies, and segments, important trends in technology development, next-generation technologies, major opportunities and market shares of key players and innovative drugs. Wellesley, Mass (PRWEB) January 13, 2014 According to a new technical market research report, Cancer Profiling and Pathways: Technologies and...

2014-01-13 16:26:15

GENSIGNIA plans to introduce minimally invasive diagnostic test which is urgently needed to improve the diagnostic performance of high resolution imaging for lung cancer detection LONDON, MILAN, and SAN DIEGO, Jan. 13, 2014 /PRNewswire/ -- GENSIGNIA Ltd, a London-based, privately held molecular diagnostics company with laboratory operations in San Diego, CA, and Fondazione IRCCS, Istituto Nazionale dei Tumori (INT), Milan, a National Cancer Research Center in Italy, announced...

2014-01-13 16:26:06

DUBLIN, Ireland, January 13, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/gxn8lj/bioinformatics) has announced the addition of the "Global Bioinformatics Market 2013 - 2017" [http://www.researchandmarkets.com/research/gxn8lj/bioinformatics ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Based on the use of bioinformatics, the various sectors covered in this report are medicine,...

2014-01-13 08:27:55

TARRYTOWN, N.Y., Jan. 13, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it has launched a new human genetics initiative via a new wholly owned subsidiary, the Regeneron Genetics Center LLC (RGC). The objective of the RGC is to expand the use of human genetics for defining disease targets and improving the drug development process. The RGC will pursue both large population-based efforts as well as family-based approaches. Central to the...

2014-01-13 08:27:30

High Quality Draft of Ancestor Genome to Inform Understanding of Complex Wheat Genome SAN DIEGO, Jan. 13, 2014 /PRNewswire/ -- BioNano Genomics announced today the purchase of an Irys((TM) )System by UC Davis to assist, among other projects, in completing the genome assembly of Aegilops tauschii, one of three progenitors of today's bread wheat. The team of researchers at UC Davis, led by Dr. Jan Dvorak, will use the Irys System in their workflow as they determine the sequence,...

2014-01-13 04:20:54

GERMANTOWN, Maryland, and HILDEN, Germany, January 13, 2014 /PRNewswire/ -- - Expanding collaboration to develop FDA-regulated diagnostics based on exosomes to measure gene mutations targeted by new anti-cancer therapies - Non-invasive detection of biomarkers from blood reduces patient risk and advances access to the benefits of personalized medicine - Automated biofluid-based molecular diagnostics have significant potential to...

2014-01-13 04:20:53

-- Collaboration will focus on enabling detection of known cancer biomarkers in blood plasma NEW YORK, Jan. 13, 2014 /PRNewswire/ -- Exosome Diagnostics today announced an expansion of its strategic collaboration with QIAGEN to develop non-invasive molecular diagnostics for use in detecting and monitoring actionable genetic mutations in lung cancer patients. In contrast with current molecular diagnostics requiring tissue biopsy, the focus will be to enable detection of...

2014-01-10 08:23:34

Irys System Provides Comprehensive and Actionable Picture of Genome Architecture SAN DIEGO, Jan. 10, 2014 /PRNewswire/ -- BioNano Genomics announced today that Erik Holmlin, Ph.D., BioNano's president and CEO, will present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 16th at 12:00 p.m. PST. About BioNano Genomics Headquartered in San Diego, BioNano Genomics is delivering an altogether better way of gaining a fully informed...

2014-01-09 12:26:51

NEW YORK, Jan. 9, 2014 /PRNewswire/ -- The New York Genome Center (NYGC) announced that New York State Governor Andrew M. Cuomo proposed in his State of the State address Wednesday afternoon a $105 million partnership between the NYGC and the University at Buffalo's Center for Computational Research, enabling genetic discoveries that will potentially save lives by transforming how health care impacts patients. Governor Cuomo's commitment to vastly enhancing the genomic medicine...